Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …
European regulators have approved a licence extension for diabetes treatment Onglyza, making it the first drug in its class that …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

